Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 8:00 AM ET

Date/Time Source News Release
07/05/2023 06:11 PM EDT GlobeNewswire Nymox Delisting from NASDAQ
05/10/2023 10:00 AM EDT GlobeNewswire Nymox Provides Current Update
04/03/2023 09:30 AM EDT GlobeNewswire Nymox Provides Corporate Update
03/21/2023 10:00 AM EDT GlobeNewswire Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer
03/15/2023 09:30 AM EDT GlobeNewswire Nymox Officially Granted Extension to Regain Listing Requirements
02/15/2023 11:50 AM EST GlobeNewswire Nymox Announces NYMOZARFEX Marketing Application is Accepted For Review
01/06/2023 04:30 PM EST GlobeNewswire NYMOX Appeals Deficiency Letter
12/05/2022 09:30 AM EST GlobeNewswire NYMOX Announces New Marketing Submission for NYMOZARFEX(TM) for BPH
11/25/2022 03:10 PM EST GlobeNewswire May 2023 Market Cap Requirement Update
09/13/2022 09:30 AM EDT GlobeNewswire NYMOX Provides Current Update
Page

Additional News

As of June 7, 2025 • 8:00 AM ET

Date/Time Source News Release
07/06/2023 04:15 AM EDT SeekingAlpha Nymox Pharmaceutical receives potential delisting notice from Nasdaq
03/21/2023 10:05 AM EDT SeekingAlpha Nymox names industry veteran as CFO
12/06/2022 02:21 PM EST PennyStocks.com Best Penny Stocks To Buy? 7 Under $1 To Watch Now
12/05/2022 11:29 AM EST PennyStocks.com Best Penny Stocks To Buy? 4 Under $1 To Watch Now
09/13/2022 09:55 AM EDT SeekingAlpha Nymox gets FDA feedback on NDA resubmission for lead asset
07/15/2022 11:39 AM EDT SeekingAlpha Nymox Pharmaceutical up 37% as it assures shareholders company is well funded
07/14/2022 02:34 PM EDT SeekingAlpha NYMOX stock down 7.2% after receiving non-compliance letter from Nasdaq
05/23/2022 01:06 PM EDT SeekingAlpha HIVE, XIN and NEON among mid-day movers
05/23/2022 10:01 AM EDT SeekingAlpha GeoVax, Entasis top healthcare gainers, while Nymox, Evoke Pharma lead losers' pack
05/23/2022 09:29 AM EDT SeekingAlpha NYMOX down 46% on Refuse to File letter from FDA for fexapotide for enlarged prostate
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.